| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RELN IGF1R FBN1 PDGFRB PIK3CG TBCK LRRK2 CD40 TBC1D2B BCL2L2 LTF POLG2 STAT3 | 2.24e-05 | 1028 | 67 | 13 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 2.82e-05 | 490 | 67 | 9 | GO:0051347 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RELN MFNG IGF1R FBN1 PDGFRB PIK3CG PDZK1 TBCK LRRK2 CD40 TBC1D2B BCL2L2 LTF POLG2 STAT3 | 4.27e-05 | 1430 | 67 | 15 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 4.89e-05 | 405 | 67 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RELN IGF1R FBN1 NSMF CD244 PDGFRB PIK3CG LRRK2 CD40 LTF STAT3 | 1.14e-04 | 879 | 67 | 11 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RELN IGF1R FBN1 NSMF CD244 PDGFRB PIK3CG LRRK2 CD40 LTF STAT3 | 1.14e-04 | 879 | 67 | 11 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 1.38e-04 | 350 | 67 | 7 | GO:0045860 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast development | 1.55e-04 | 6 | 67 | 2 | GO:2001205 | |
| Domain | Quino_amine_DH_bsu | 6.47e-05 | 22 | 67 | 3 | IPR011044 | |
| Domain | PINIT | 7.57e-05 | 4 | 67 | 2 | IPR023321 | |
| Domain | PINIT | 7.57e-05 | 4 | 67 | 2 | PS51466 | |
| Domain | PINIT | 7.57e-05 | 4 | 67 | 2 | PF14324 | |
| Domain | zf-MIZ | 2.63e-04 | 7 | 67 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 2.63e-04 | 7 | 67 | 2 | PS51044 | |
| Domain | Znf_MIZ | 3.50e-04 | 8 | 67 | 2 | IPR004181 | |
| Domain | Peptidase_M12B_N | 3.68e-04 | 39 | 67 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.68e-04 | 39 | 67 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.96e-04 | 40 | 67 | 3 | PS00427 | |
| Domain | Reprolysin | 3.96e-04 | 40 | 67 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.96e-04 | 40 | 67 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.96e-04 | 40 | 67 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.96e-04 | 40 | 67 | 3 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 4.27e-04 | 41 | 67 | 3 | PS00546 | |
| Domain | Disintegrin_dom | 4.27e-04 | 41 | 67 | 3 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 4.91e-04 | 43 | 67 | 3 | IPR001818 | |
| Domain | Kinase-like_dom | 6.92e-04 | 542 | 67 | 8 | IPR011009 | |
| Domain | TBC | 7.22e-04 | 49 | 67 | 3 | SM00164 | |
| Domain | RabGAP-TBC | 9.09e-04 | 53 | 67 | 3 | PF00566 | |
| Domain | TBC_RABGAP | 1.01e-03 | 55 | 67 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 1.01e-03 | 55 | 67 | 3 | IPR000195 | |
| Domain | Disintegrin_CS | 1.47e-03 | 16 | 67 | 2 | IPR018358 | |
| Domain | Prot_kinase_dom | 1.81e-03 | 489 | 67 | 7 | IPR000719 | |
| Domain | ADAM_CR | 1.87e-03 | 18 | 67 | 2 | PF08516 | |
| Domain | PROTEIN_KINASE_DOM | 1.90e-03 | 493 | 67 | 7 | PS50011 | |
| Domain | - | 1.97e-03 | 148 | 67 | 4 | 2.60.40.150 | |
| Domain | - | 2.31e-03 | 20 | 67 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 2.55e-03 | 21 | 67 | 2 | PF00200 | |
| Domain | DISIN | 2.55e-03 | 21 | 67 | 2 | SM00050 | |
| Domain | - | 2.55e-03 | 21 | 67 | 2 | 1.10.720.30 | |
| Domain | SAP | 2.80e-03 | 22 | 67 | 2 | PF02037 | |
| Domain | C2_dom | 2.86e-03 | 164 | 67 | 4 | IPR000008 | |
| Domain | SAP | 3.06e-03 | 23 | 67 | 2 | SM00513 | |
| Domain | MetalloPept_cat_dom | 3.08e-03 | 81 | 67 | 3 | IPR024079 | |
| Domain | - | 3.08e-03 | 81 | 67 | 3 | 3.40.390.10 | |
| Domain | SAP | 3.61e-03 | 25 | 67 | 2 | PS50800 | |
| Domain | SAP_dom | 3.61e-03 | 25 | 67 | 2 | IPR003034 | |
| Domain | ACR | 4.20e-03 | 27 | 67 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 4.20e-03 | 27 | 67 | 2 | IPR006586 | |
| Domain | ZINC_PROTEASE | 5.26e-03 | 98 | 67 | 3 | PS00142 | |
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 9724754 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30167815 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15998644 | ||
| Pubmed | The PINIT domain of PIAS3: structure-function analysis of its interaction with STAT3. | 3.88e-06 | 2 | 69 | 2 | 21812053 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11463827 | ||
| Pubmed | Serum starvation and growth factor receptor expression in vascular smooth muscle cells. | 3.88e-06 | 2 | 69 | 2 | 16407661 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18550668 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27324722 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24266654 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25124686 | ||
| Pubmed | [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice]. | 3.88e-06 | 2 | 69 | 2 | 22699062 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9388184 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29953970 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29339537 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16098628 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 3107886 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24718277 | ||
| Pubmed | The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent. | 3.88e-06 | 2 | 69 | 2 | 19903771 | |
| Pubmed | Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling. | 3.88e-06 | 2 | 69 | 2 | 27980069 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12061821 | ||
| Pubmed | 8.32e-06 | 20 | 69 | 3 | 19862325 | ||
| Pubmed | 9.69e-06 | 21 | 69 | 3 | 18591388 | ||
| Pubmed | 1.12e-05 | 22 | 69 | 3 | 18372903 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11861293 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 32029900 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23821363 | ||
| Pubmed | Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction. | 1.16e-05 | 3 | 69 | 2 | 25808869 | |
| Pubmed | The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. | 1.16e-05 | 3 | 69 | 2 | 29572229 | |
| Pubmed | SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3. | 1.16e-05 | 3 | 69 | 2 | 31201813 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 29559623 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 30861611 | ||
| Pubmed | ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. | 1.16e-05 | 3 | 69 | 2 | 14715251 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22194466 | ||
| Pubmed | Down-regulation of ATBF1 activates STAT3 signaling via PIAS3 in pacing-induced HL-1 atrial myocytes. | 1.16e-05 | 3 | 69 | 2 | 24857987 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 36045346 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 26364612 | ||
| Pubmed | TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. | 1.16e-05 | 3 | 69 | 2 | 28100038 | |
| Pubmed | PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. | 1.16e-05 | 3 | 69 | 2 | 12077349 | |
| Pubmed | TRIM8 modulates STAT3 activity through negative regulation of PIAS3. | 1.16e-05 | 3 | 69 | 2 | 20516148 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 17568996 | ||
| Pubmed | Jak1-STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis. | 1.16e-05 | 3 | 69 | 2 | 27440725 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23322197 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11429412 | ||
| Pubmed | Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. | 1.16e-05 | 3 | 69 | 2 | 16368885 | |
| Pubmed | Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. | 1.16e-05 | 3 | 69 | 2 | 15572665 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 30054984 | ||
| Pubmed | Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets. | 1.16e-05 | 3 | 69 | 2 | 22120672 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23591770 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12804609 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 26116514 | ||
| Pubmed | Elevation of LncRNA ENST00000453774.1 Prevents Renal Fibrosis by Upregulating FBN1, IGF1R, and KLF7. | 1.16e-05 | 3 | 69 | 2 | 34614499 | |
| Pubmed | Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. | 1.29e-05 | 23 | 69 | 3 | 33898467 | |
| Pubmed | Genome-wide Identification of Foxf2 Target Genes in Palate Development. | 1.29e-05 | 23 | 69 | 3 | 32040930 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 26183824 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 23857432 | ||
| Pubmed | MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. | 2.32e-05 | 4 | 69 | 2 | 27259262 | |
| Pubmed | Migration of dorsal aorta mesenchymal stem cells induced by mouse embryonic circulation. | 2.32e-05 | 4 | 69 | 2 | 21089075 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 16382134 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 34402888 | ||
| Pubmed | IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis. | 2.32e-05 | 4 | 69 | 2 | 28223169 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 28988111 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 32968170 | ||
| Pubmed | Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells. | 2.32e-05 | 4 | 69 | 2 | 31235784 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11477070 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 28035977 | ||
| Pubmed | Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition. | 2.32e-05 | 4 | 69 | 2 | 29950561 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 18079201 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 19492417 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 15907835 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 31747314 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 19890347 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 26840943 | ||
| Pubmed | SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death. | 3.86e-05 | 5 | 69 | 2 | 28622293 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 27358915 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 28035384 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 17975158 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 27703003 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 19247373 | ||
| Pubmed | Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. | 5.79e-05 | 6 | 69 | 2 | 16029420 | |
| Pubmed | SUMOylation of RORalpha potentiates transcriptional activation function. | 5.79e-05 | 6 | 69 | 2 | 19041634 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20613589 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 18567820 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 7873879 | ||
| Pubmed | Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. | 5.79e-05 | 6 | 69 | 2 | 23861540 | |
| Pubmed | A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. | 5.79e-05 | 6 | 69 | 2 | 23704280 | |
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 6.16e-05 | 342 | 69 | 6 | 23128233 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 7.76e-05 | 113 | 69 | 4 | 34474245 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 10848613 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 17471507 | ||
| Pubmed | Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. | 8.09e-05 | 7 | 69 | 2 | 19217413 | |
| Pubmed | Physical and functional interactions between STAT3 and KAP1. | 8.09e-05 | 7 | 69 | 2 | 18037959 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 15254021 | ||
| Pubmed | 9.34e-05 | 44 | 69 | 3 | 27224923 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 1.08e-04 | 8 | 69 | 2 | 23055981 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 26315405 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11117529 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 7819129 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 16522640 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ATP6V1H IGF1R PIAS3 PDGFRB CD40 RBM15B SLFN5 LTF PIAS2 STAT3 | 1.26e-04 | 1203 | 69 | 10 | 29180619 |
| Pubmed | Positional cloning of the combined hyperlipidemia gene Hyplip1. | 1.38e-04 | 9 | 69 | 2 | 11753387 | |
| GeneFamily | Zinc fingers MIZ-type | 1.82e-04 | 7 | 54 | 2 | 85 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-05 | 261 | 66 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | TGFB3 VSNL1 FBN1 NSMF TRMT2A MYO7A LRRK2 JAZF1 L2HGDH ATP8B1 SMOC2 NEK9 ADGRL3 | 4.43e-05 | 1148 | 66 | 13 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 9.15e-05 | 146 | 66 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 9.23e-05 | 76 | 66 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-07 | 182 | 69 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-06 | 157 | 69 | 5 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | Tuft-tuft-1|World / Class top | 6.34e-06 | 168 | 69 | 5 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 176 | 69 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 178 | 69 | 5 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 178 | 69 | 5 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 8.62e-06 | 179 | 69 | 5 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.62e-06 | 179 | 69 | 5 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.10e-06 | 181 | 69 | 5 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-06 | 183 | 69 | 5 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 185 | 69 | 5 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 186 | 69 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.18e-05 | 191 | 69 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 69 | 5 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 69 | 5 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 69 | 5 | b2d295e330772bd8e24da356c75564b4297ea9c5 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 69 | 5 | ce59ee3d970397eb62d6387699c6c6cd65457898 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 69 | 5 | 3ffaea4b44067d69f954b2bd3119c88a55ab232a | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.44e-05 | 199 | 69 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.44e-05 | 199 | 69 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-05 | 200 | 69 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 200 | 69 | 5 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.47e-05 | 200 | 69 | 5 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.47e-05 | 200 | 69 | 5 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.47e-05 | 200 | 69 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 200 | 69 | 5 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 200 | 69 | 5 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 200 | 69 | 5 | fc2fc3bfcf1ad9bfb9fe07bbed8068126930bee6 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.47e-05 | 200 | 69 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.47e-05 | 200 | 69 | 5 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.54e-05 | 127 | 69 | 4 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 159 | 69 | 4 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 159 | 69 | 4 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-04 | 160 | 69 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.11e-04 | 160 | 69 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.14e-04 | 161 | 69 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 163 | 69 | 4 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 163 | 69 | 4 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 164 | 69 | 4 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 164 | 69 | 4 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 165 | 69 | 4 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 165 | 69 | 4 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.31e-04 | 167 | 69 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.34e-04 | 168 | 69 | 4 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.47e-04 | 172 | 69 | 4 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 172 | 69 | 4 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 174 | 69 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 178 | 69 | 4 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 178 | 69 | 4 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 179 | 69 | 4 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 180 | 69 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 181 | 69 | 4 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.79e-04 | 181 | 69 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 182 | 69 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 183 | 69 | 4 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.90e-04 | 184 | 69 | 4 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 1.90e-04 | 184 | 69 | 4 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.94e-04 | 185 | 69 | 4 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.94e-04 | 185 | 69 | 4 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.94e-04 | 185 | 69 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 1.94e-04 | 185 | 69 | 4 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-04 | 185 | 69 | 4 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-04 | 186 | 69 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 186 | 69 | 4 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.98e-04 | 186 | 69 | 4 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.02e-04 | 187 | 69 | 4 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-04 | 187 | 69 | 4 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-04 | 187 | 69 | 4 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-04 | 187 | 69 | 4 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 2.06e-04 | 188 | 69 | 4 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-04 | 188 | 69 | 4 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-04 | 188 | 69 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-04 | 188 | 69 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 2.06e-04 | 188 | 69 | 4 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-04 | 188 | 69 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 2.06e-04 | 188 | 69 | 4 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-04 | 190 | 69 | 4 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 190 | 69 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 190 | 69 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-04 | 190 | 69 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-04 | 191 | 69 | 4 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-04 | 191 | 69 | 4 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.19e-04 | 191 | 69 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| Drug | tetrathiomolybdate | 3.65e-06 | 78 | 68 | 5 | ctd:C020809 | |
| Disease | Crohn's disease (is_implicated_in) | 3.97e-05 | 30 | 65 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | Gastrointestinal Hemorrhage | 1.70e-04 | 9 | 65 | 2 | C0017181 | |
| Disease | Fibrosis | 1.86e-04 | 50 | 65 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.86e-04 | 50 | 65 | 3 | C1623038 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 2.89e-04 | 58 | 65 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | complex trait | 3.32e-04 | 271 | 65 | 5 | EFO_0010578 | |
| Disease | hematologic cancer (implicated_via_orthology) | 3.67e-04 | 13 | 65 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | skin melanoma (is_marker_for) | 3.67e-04 | 13 | 65 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Crohn's disease | 4.23e-04 | 441 | 65 | 6 | EFO_0000384 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 4.27e-04 | 14 | 65 | 2 | DOID:10873 (is_marker_for) | |
| Disease | lymphocyte:monocyte ratio | 4.38e-04 | 288 | 65 | 5 | EFO_0600088 | |
| Disease | Endometrioma | 4.46e-04 | 161 | 65 | 4 | C0269102 | |
| Disease | Endometriosis | 4.46e-04 | 161 | 65 | 4 | C0014175 | |
| Disease | renal cell carcinoma (is_implicated_in) | 4.82e-04 | 69 | 65 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 4.88e-04 | 295 | 65 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 6.36e-04 | 17 | 65 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Congenital hernia of foramen of Morgagni | 7.98e-04 | 19 | 65 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 7.98e-04 | 19 | 65 | 2 | C0265700 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 8.85e-04 | 20 | 65 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 9.77e-04 | 21 | 65 | 2 | C0235833 | |
| Disease | cerebrospinal fluid biomarker measurement | 1.26e-03 | 96 | 65 | 3 | EFO_0006794 | |
| Disease | Acute Confusional Senile Dementia | 1.38e-03 | 99 | 65 | 3 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.38e-03 | 99 | 65 | 3 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.38e-03 | 99 | 65 | 3 | C0750901 | |
| Disease | Presenile dementia | 1.38e-03 | 99 | 65 | 3 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 1.38e-03 | 99 | 65 | 3 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.42e-03 | 100 | 65 | 3 | C0276496 | |
| Disease | Alzheimer's Disease | 1.46e-03 | 101 | 65 | 3 | C0002395 | |
| Disease | Endogenous Hyperinsulinism | 1.50e-03 | 26 | 65 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.50e-03 | 26 | 65 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.50e-03 | 26 | 65 | 2 | C1257965 | |
| Disease | pancreatic ductal adenocarcinoma (is_marker_for) | 1.62e-03 | 27 | 65 | 2 | DOID:3498 (is_marker_for) | |
| Disease | lifestyle measurement, depressive symptom measurement | 1.63e-03 | 105 | 65 | 3 | EFO_0007006, EFO_0010724 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.74e-03 | 28 | 65 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | stimulant use measurement | 1.74e-03 | 28 | 65 | 2 | EFO_0600076 | |
| Disease | Hyperinsulinism | 1.74e-03 | 28 | 65 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 2.00e-03 | 30 | 65 | 2 | C1855520 | |
| Disease | Hyperglycemia | 2.00e-03 | 30 | 65 | 2 | C0020456 | |
| Disease | migraine disorder, glucose measurement | 2.13e-03 | 31 | 65 | 2 | EFO_0004468, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKLYFGQKCPRVNGV | 161 | A0FGR9 | |
| PGNIFRLKYCGNLVV | 401 | O43506 | |
| KVFLCPGLLKGVYQS | 131 | Q9HAR2 | |
| KLRQKGYVCGAGPGE | 21 | Q92843 | |
| GNCRKLGAPKVFYIA | 71 | Q7Z5J1 | |
| IVRTPEGNIKLYCKG | 606 | O43520 | |
| LEYCVGIIGGKPKQS | 316 | Q96DT6 | |
| VIGRNPIKIGYGKAN | 401 | Q8NDT2 | |
| RGKICEAKNLLPYLG | 41 | Q15283 | |
| PKLCRLAKGENGYGF | 376 | Q5T2W1 | |
| YNKYIQKPGLLGRTC | 191 | Q86WK9 | |
| CIVQRQKIAYLGGKG | 231 | Q92813 | |
| CGQLGVGNYKKRLGI | 626 | Q8TD19 | |
| VGNYKKRLGINLLGG | 631 | Q8TD19 | |
| ALYEKGLQNGVPGLR | 151 | Q9H9P8 | |
| PVPGCKKRYKNVNGI | 176 | Q86VZ6 | |
| CQYGPRRKGFQLKKV | 286 | Q8N187 | |
| RKYGGAKLNRLNPGN | 886 | P08069 | |
| AGGFQQRQGLKYCLP | 181 | Q9UK99 | |
| IARPGKVCQLSLGGY | 366 | P21128 | |
| NRFIGNPGIQKCGLK | 551 | Q5S007 | |
| CQGGPGHLYLLKNKV | 411 | Q6X4W1 | |
| NKRLPYGLAQIGVCF | 201 | Q9UHN1 | |
| SLTYLRPLQGQKCGG | 1441 | A2RRP1 | |
| RPLQGQKCGGAYQIG | 1446 | A2RRP1 | |
| KPGYVLQFKLNIGCA | 1296 | P78509 | |
| QVVGTYRCLPGKKGG | 236 | P25205 | |
| VPGGAAVGVKLKYCR | 36 | Q58A45 | |
| DIKGGYQKPQICDLL | 231 | Q9H1X3 | |
| NIPGLGYVLKRCGNK | 391 | Q9UKF2 | |
| NRPEPKNGGKYCVGR | 616 | Q9P2N4 | |
| GSGIPEVKCYLNGVK | 156 | P51797 | |
| KGPYCLLQGIGRRKD | 66 | H3BNL1 | |
| QVDPICGKGYSRIKG | 891 | P35555 | |
| AYLKNKDGLVISCGP | 901 | Q8TF46 | |
| GRGKYKKGFSVNPRC | 2281 | O75417 | |
| TVYRLLKCAPRGKNG | 521 | Q9BSK4 | |
| LLLLKVYQGKGCQGS | 11 | Q9BZW8 | |
| GYIIECKLGGRLQPS | 236 | O00587 | |
| NLLGACTKGGPIYII | 666 | P09619 | |
| CIKVNGKLFPLPGYA | 231 | O75928 | |
| GCKQFIRGKPIRFGY | 281 | Q8N328 | |
| GPPLIKSGYCVKQGN | 196 | Q9HB19 | |
| RLGKYKGGTCAVAAP | 261 | Q8IZ69 | |
| YPRGKRVIEQLGGKQ | 421 | Q9UI12 | |
| AGKCGLVPVLAENYK | 421 | P02788 | |
| SCPRLGYQAKLFKGV | 296 | Q6XZB0 | |
| NGYCVRVPKGEVGLL | 411 | O14975 | |
| FRCNYLALVGGGKKP | 61 | Q5MNZ6 | |
| QRILQDPVYGKGKLG | 1191 | Q8N3P4 | |
| QKLCPGGQLPFLLYG | 56 | O00299 | |
| GALLNLQIYCGKAPA | 426 | P48736 | |
| LFVKVNGKLCPLPGY | 211 | Q9Y6X2 | |
| GPQGPKGAEKRYLCQ | 141 | A6NM28 | |
| APAGGAAYVKRLCKG | 11 | Q8TDR2 | |
| YKGFLKDCPSGRLNL | 31 | P62760 | |
| FNSRNCYGKGLKGPL | 521 | Q9H5L6 | |
| GRFLVNGQCGYVLKP | 626 | Q8N3E9 | |
| KARDLYKGRQLQGCP | 291 | Q9H3U7 | |
| KLLGPGVNYSGCQIT | 531 | P40763 | |
| KYPRICILDGGINKI | 866 | Q8TEA7 | |
| SGKYGGNCLLPAQLV | 166 | P21506 | |
| KVQKGGYNGLNQCLP | 121 | Q96N22 | |
| RYGGGPRLTVKALCK | 541 | Q86UV5 | |
| VRGEGQKAKLYCAPI | 31 | A0A087WV62 | |
| RLCGYLQKLSGKGPL | 36 | Q9UPU7 | |
| QKLVNKGGYTGRLCI | 476 | Q08AF3 | |
| AKQRYIGGKNLPTRG | 181 | P10600 | |
| RGGKTLCKGYRQAPP | 376 | P35125 | |
| KYCDPNLGLRVQQKG | 81 | P25942 | |
| NKVLIKEYGCGPSGQ | 306 | Q86VY4 | |
| GVKPAYKQGDLRGTC | 691 | Q13402 |